Clinical outcomes of abiraterone acetate and predictors of its treatment duration in metastatic castration‐resistant prostate cancer: Real‐world experience in the Southeast Asian cohort.
Saved in:
| Title: | Clinical outcomes of abiraterone acetate and predictors of its treatment duration in metastatic castration‐resistant prostate cancer: Real‐world experience in the Southeast Asian cohort. |
|---|---|
| Authors: | Lim, Jasmine1 (AUTHOR), Amantakul, Akara2 (AUTHOR), Shariff, Nisha3 (AUTHOR), Lojanapiwat, Bannakij2 (AUTHOR) bannakij.lojana@cmu.ac.th, Alip, Adlinda3 (AUTHOR), Ong, Teng Aik1 (AUTHOR), Thevarajah, Shankaran4 (AUTHOR), Ahmayuddin, Firdaus4 (AUTHOR), Mathew, Adeline5 (AUTHOR), Sriplakich, Supon2 (AUTHOR), Vuthiwong, Jaraspong2 (AUTHOR), Chong, Flora Li Tze5 (AUTHOR), Saad, Marniza3 (AUTHOR) marniza@ummc.edu.my |
| Source: | Cancer Medicine. Jul2020, Vol. 9 Issue 13, p4613-4621. 9p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20457634 |
|---|---|
| DOI: | 10.1002/cam4.3101 |
